-
3
pages
-
English
-
Documents
-
2015
Description
Xarelto (rivaroxaban) is one of the latest anti-coagulation, or blood thinning, medications approved for use by the FDA. The drug is an oral medication developed by Bayer and Johnson & Johnson. Blood thinning medication works by preventing dangerous blood clots that can move throughout the body and cause an obstruction of blood flow to the vital organs.
-
Publié par
-
Publié le
18 juin 2015
-
Langue
English